US Stock MarketDetailed Quotes

NVO Novo-Nordisk A/S

Watchlist
  • 110.130
  • +0.410+0.37%
Close Nov 5 16:00 ET
  • 109.670
  • -0.460-0.42%
Pre 07:43 ET
490.75BMarket Cap37.43P/E (TTM)

Novo-Nordisk A/S Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
25.34%68.06B
22.45%65.35B
31.26%232.26B
36.95%65.86B
28.89%58.73B
31.59%54.3B
26.97%53.37B
25.68%176.95B
25.46%48.09B
27.92%45.57B
Operating revenue
25.34%68.06B
22.45%65.35B
33.56%608.65B
35.31%442.25B
28.89%58.73B
31.59%54.3B
26.97%53.37B
33.96%455.69B
37.49%326.83B
27.92%45.57B
Cost of revenue
30.78%10.27B
21.19%9.92B
25.72%35.77B
21.21%10.01B
34.90%9.71B
29.44%7.86B
18.29%8.18B
20.25%28.45B
32.38%8.26B
18.83%7.2B
Gross profit
24.42%57.79B
22.68%55.43B
32.32%196.5B
40.22%55.85B
27.76%49.02B
31.96%46.44B
28.68%45.19B
26.77%148.51B
24.11%39.83B
29.78%38.37B
Operating expense
41.21%31.85B
16.89%23.59B
27.44%93.92B
27.88%29.08B
21.58%22.11B
34.22%22.56B
26.37%20.18B
25.98%73.7B
23.21%22.74B
27.02%18.18B
Selling and administrative expenses
4.39%16.09B
6.90%14.41B
21.53%61.6B
23.42%18.63B
11.63%14.08B
30.28%15.41B
20.89%13.48B
23.44%50.68B
17.70%15.09B
24.31%12.61B
-Selling and marketing expense
4.13%14.93B
6.80%13.26B
22.78%56.74B
24.94%17.17B
11.95%12.82B
32.31%14.34B
21.89%12.41B
24.88%46.22B
18.15%13.74B
25.57%11.45B
-General and administrative expense
7.93%1.16B
8.03%1.16B
8.69%4.86B
8.01%1.46B
8.46%1.26B
8.17%1.07B
10.41%1.07B
10.30%4.47B
13.28%1.35B
13.09%1.16B
Research and development costs
126.83%16.17B
27.91%8.61B
34.91%32.44B
29.38%10.46B
44.29%8.13B
39.12%7.13B
29.24%6.73B
35.31%24.05B
43.55%8.09B
32.48%5.63B
Other operating expenses
-2,800.00%-405M
1,821.21%568M
88.49%-119M
99.31%-3M
-63.33%-98M
110.07%15M
91.58%-33M
-211.45%-1.03B
-10,925.00%-433M
25.93%-60M
Operating profit
8.56%25.93B
27.35%31.85B
37.11%102.57B
56.65%26.77B
33.34%26.91B
29.89%23.89B
30.61%25.01B
27.56%74.81B
25.33%17.09B
32.36%20.18B
Net non-operating interest income expense
-264.48%-602M
126.67%72M
203.13%330M
-119.67%-916M
153.44%1.15B
122.93%366M
78.01%-270M
-77.78%-320M
509.50%4.66B
-1,470.80%-2.15B
Non-operating interest income
48.38%960M
151.88%2.15B
347.28%1.07B
11.88%-2.82B
110.93%3.32B
-60.93%647M
305.71%852M
3.46%239M
-33.22%-3.2B
99.11%1.57B
Non-operating interest expense
455.87%1.56B
84.85%2.07B
43.39%542M
73.86%-2.1B
-41.80%2.17B
-91.36%281M
-21.97%1.12B
30.80%378M
-479.45%-8.04B
301.83%3.73B
Total other finance cost
----
----
8.84%197M
----
----
----
----
48.36%181M
----
----
Other net income (expense)
132.61%1.77B
-981.01%-5.43B
Gain on sale of security
----
----
132.25%1.69B
----
----
----
----
-918.44%-5.24B
----
----
Earnings from equity interest
----
----
142.86%81M
----
----
----
----
-687.50%-189M
----
----
Income before tax
4.44%25.33B
29.03%31.92B
51.57%104.67B
69.28%27.62B
55.63%28.06B
44.41%24.25B
38.05%24.74B
16.90%69.06B
24.43%16.32B
19.32%18.03B
Income tax
9.45%5.28B
32.26%6.51B
55.06%20.99B
107.67%5.66B
53.98%5.59B
38.80%4.83B
32.73%4.92B
19.55%13.54B
22.65%2.72B
21.18%3.63B
Net income
3.20%20.05B
28.23%25.41B
50.71%83.68B
61.59%21.96B
56.04%22.48B
45.88%19.43B
39.44%19.81B
16.27%55.53B
24.79%13.59B
18.86%14.41B
Net income continuous Operations
3.20%20.05B
28.23%25.41B
50.71%83.68B
61.59%21.96B
56.04%22.48B
45.88%19.43B
39.44%19.81B
16.27%55.53B
24.79%13.59B
18.86%14.41B
Minority interest income
Net income attributable to the parent company
3.20%20.05B
28.23%25.41B
50.71%83.68B
61.59%21.96B
56.04%22.48B
45.88%19.43B
39.44%19.81B
16.27%55.53B
24.79%13.59B
18.86%14.41B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
3.20%20.05B
28.23%25.41B
50.71%83.68B
61.59%21.96B
56.04%22.48B
45.88%19.43B
39.44%19.81B
16.27%55.53B
24.79%13.59B
18.86%14.41B
Basic earnings per share
3.93%4.5
29.55%5.7
52.28%18.67
62.91%4.92
57.37%5.02
47.53%4.33
41.03%4.4
17.88%12.26
26.36%3.02
20.60%3.19
Diluted earnings per share
3.94%4.49
29.38%5.68
52.37%18.62
63.12%4.91
57.73%5
47.44%4.32
41.16%4.39
17.84%12.22
26.47%3.01
20.30%3.17
Dividend per share
0
59.41%6.4281
26.94%7.0451
0
40.55%3.0126
0
18.37%4.0325
19.10%5.55
0
23.56%2.1434
Currency Unit
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
DKK
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 25.34%68.06B22.45%65.35B31.26%232.26B36.95%65.86B28.89%58.73B31.59%54.3B26.97%53.37B25.68%176.95B25.46%48.09B27.92%45.57B
Operating revenue 25.34%68.06B22.45%65.35B33.56%608.65B35.31%442.25B28.89%58.73B31.59%54.3B26.97%53.37B33.96%455.69B37.49%326.83B27.92%45.57B
Cost of revenue 30.78%10.27B21.19%9.92B25.72%35.77B21.21%10.01B34.90%9.71B29.44%7.86B18.29%8.18B20.25%28.45B32.38%8.26B18.83%7.2B
Gross profit 24.42%57.79B22.68%55.43B32.32%196.5B40.22%55.85B27.76%49.02B31.96%46.44B28.68%45.19B26.77%148.51B24.11%39.83B29.78%38.37B
Operating expense 41.21%31.85B16.89%23.59B27.44%93.92B27.88%29.08B21.58%22.11B34.22%22.56B26.37%20.18B25.98%73.7B23.21%22.74B27.02%18.18B
Selling and administrative expenses 4.39%16.09B6.90%14.41B21.53%61.6B23.42%18.63B11.63%14.08B30.28%15.41B20.89%13.48B23.44%50.68B17.70%15.09B24.31%12.61B
-Selling and marketing expense 4.13%14.93B6.80%13.26B22.78%56.74B24.94%17.17B11.95%12.82B32.31%14.34B21.89%12.41B24.88%46.22B18.15%13.74B25.57%11.45B
-General and administrative expense 7.93%1.16B8.03%1.16B8.69%4.86B8.01%1.46B8.46%1.26B8.17%1.07B10.41%1.07B10.30%4.47B13.28%1.35B13.09%1.16B
Research and development costs 126.83%16.17B27.91%8.61B34.91%32.44B29.38%10.46B44.29%8.13B39.12%7.13B29.24%6.73B35.31%24.05B43.55%8.09B32.48%5.63B
Other operating expenses -2,800.00%-405M1,821.21%568M88.49%-119M99.31%-3M-63.33%-98M110.07%15M91.58%-33M-211.45%-1.03B-10,925.00%-433M25.93%-60M
Operating profit 8.56%25.93B27.35%31.85B37.11%102.57B56.65%26.77B33.34%26.91B29.89%23.89B30.61%25.01B27.56%74.81B25.33%17.09B32.36%20.18B
Net non-operating interest income expense -264.48%-602M126.67%72M203.13%330M-119.67%-916M153.44%1.15B122.93%366M78.01%-270M-77.78%-320M509.50%4.66B-1,470.80%-2.15B
Non-operating interest income 48.38%960M151.88%2.15B347.28%1.07B11.88%-2.82B110.93%3.32B-60.93%647M305.71%852M3.46%239M-33.22%-3.2B99.11%1.57B
Non-operating interest expense 455.87%1.56B84.85%2.07B43.39%542M73.86%-2.1B-41.80%2.17B-91.36%281M-21.97%1.12B30.80%378M-479.45%-8.04B301.83%3.73B
Total other finance cost --------8.84%197M----------------48.36%181M--------
Other net income (expense) 132.61%1.77B-981.01%-5.43B
Gain on sale of security --------132.25%1.69B-----------------918.44%-5.24B--------
Earnings from equity interest --------142.86%81M-----------------687.50%-189M--------
Income before tax 4.44%25.33B29.03%31.92B51.57%104.67B69.28%27.62B55.63%28.06B44.41%24.25B38.05%24.74B16.90%69.06B24.43%16.32B19.32%18.03B
Income tax 9.45%5.28B32.26%6.51B55.06%20.99B107.67%5.66B53.98%5.59B38.80%4.83B32.73%4.92B19.55%13.54B22.65%2.72B21.18%3.63B
Net income 3.20%20.05B28.23%25.41B50.71%83.68B61.59%21.96B56.04%22.48B45.88%19.43B39.44%19.81B16.27%55.53B24.79%13.59B18.86%14.41B
Net income continuous Operations 3.20%20.05B28.23%25.41B50.71%83.68B61.59%21.96B56.04%22.48B45.88%19.43B39.44%19.81B16.27%55.53B24.79%13.59B18.86%14.41B
Minority interest income
Net income attributable to the parent company 3.20%20.05B28.23%25.41B50.71%83.68B61.59%21.96B56.04%22.48B45.88%19.43B39.44%19.81B16.27%55.53B24.79%13.59B18.86%14.41B
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 3.20%20.05B28.23%25.41B50.71%83.68B61.59%21.96B56.04%22.48B45.88%19.43B39.44%19.81B16.27%55.53B24.79%13.59B18.86%14.41B
Basic earnings per share 3.93%4.529.55%5.752.28%18.6762.91%4.9257.37%5.0247.53%4.3341.03%4.417.88%12.2626.36%3.0220.60%3.19
Diluted earnings per share 3.94%4.4929.38%5.6852.37%18.6263.12%4.9157.73%547.44%4.3241.16%4.3917.84%12.2226.47%3.0120.30%3.17
Dividend per share 059.41%6.428126.94%7.0451040.55%3.0126018.37%4.032519.10%5.55023.56%2.1434
Currency Unit DKKDKKDKKDKKDKKDKKDKKDKKDKKDKK
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Weight Loss Drugs
Weight Loss Drugs
Intraday+0.28%